Optherion's Series A - II Round

Optherion raised a round of funding on September 18, 2009.

Optherion, Inc. is an early-stage biotechnology company that is developing products to treat and diagnose dry and wet Age-related Macular Degeneration (AMD) and other chronic diseases involving the al…

Articles about Optherion's Series A - II Round: